You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
| Title |
ErbB2+ metastatic breast cancer treatment after progression on trastuzumab: a cost-effectiveness analysis for a developing country.
|
|---|---|
| Published in |
Revista de Salud Pública, May 2014
|
| DOI | 10.15446/rsap.v16n2.31690 |
| Pubmed ID | |
| Authors |
Mario García Molina, Liliana Alejandra Chicaíza-Becerra, Liliana Alejandra Chicaíza-Becerra, Carlos Castañeda, Carlos Castañeda, Oscar Gamboa Garay, Oscar Gamboa Garay |
Mendeley readers
The data shown below were compiled from readership statistics for 94 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 94 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 20 | 21% |
| Student > Master | 15 | 16% |
| Other | 7 | 7% |
| Lecturer | 6 | 6% |
| Student > Ph. D. Student | 6 | 6% |
| Other | 14 | 15% |
| Unknown | 26 | 28% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 26 | 28% |
| Pharmacology, Toxicology and Pharmaceutical Science | 10 | 11% |
| Economics, Econometrics and Finance | 10 | 11% |
| Social Sciences | 4 | 4% |
| Nursing and Health Professions | 2 | 2% |
| Other | 8 | 9% |
| Unknown | 34 | 36% |